HERON THERAPEUTICS, INC. /DE/ Increase (Decrease) in Contract with Customer, Liability
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Increase (Decrease) in Contract with Customer, Liability of $1.66 million for the 12-month period ending 2017-12-31, per its 10-K filed 2020-03-02.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2020-03-02
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in contract with customer, liability for fiscal 2017 was $1.66M, a 51.41% increase from fiscal 2016.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in contract with customer, liability for fiscal 2016 was $1.10M.
| Period end | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|
| 2017-12-31 | $1.66M 10-K · filed 2020-03-02 |
| 2016-12-31 | $1.10M 10-K · filed 2019-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |